Abstract:BACKGROUND: Exogenous ganglioside-1 (GM1) can cross the blood-brain barrier and play a protective role against hypoxia-ischemia-induced brain damage.OBJECTIVE: To examine the possible mechanisms of exogenous GM1 protection in hypoxia-ischemia-induced brain damage in a neonatal rat model by measuring changes in brain mass. pathological morphology, growth-associated protein-43 expression. and neurobehavioral manifestations.DESIGN, TIME AND SETTING: A randomized block-design study was performed at the Immunohistochemistry Laboratory of the pediatric Research Institute, Children's Hospital of Chongquing Medical University from August 2005 to August 2006.MATERIALS: A total of 36 neonatal, 7-day-old, Sprague Dawley rats Were used in this experiment. The hypoxia-ischemia-induced brain damage model was established by permanently Occluding the right carotid artery, followed by oxygen inhalation at a low concentration (8% O-2, 92% N-2) for 2 hours.METHODS: All rats were randomly divided into the following groups: GM1 model, and sham operation, with 12 rats each group. Rats in the GM1 and model groups received hypoxic/ischemic-induced brain damage. Rats in the GM1 group received injections of GM1 (i.p., 20 mg/kg) at 0, 24, 48, 72, 96, 120, and 144 hours following models established. and rats in the model group were administered (i.p.) the same amount of saline. The right carotid artery was separated, but not ligated, in the sham operation group rats.MAIN OUTCOME MEASURES: At 1 week after surgery expression of growth-associated protein-43, a marker of neural development and plasticity, was detected in the hippocampal CA3 region by immunohistochemistry. Brain mass was measured. and the pathological morphology was observed. At 4 weeks after surgery, behavioral changes in the remaining rats were tested by Morris water maze. and growth-associated protein-43 expression was measured.RESULTS: (1) In the GM1 and sham operation groups, growth-associated protein-43 expression was greater in the hippocampal CA3 region compared to the model group 1 week after surgery (P < 0.05). In all three groups, brain weight of the right hemisphere was significantly less than the left hemisphere, in particular in the model group (P < 0.05). In the GM1 group, the weight difference between two hemispheres, as well as the extent of damage in the rig-lit hemisphere. was less than the model group (P < 0.01). In the sham operation group. brain tissue consisted of integrated structures and ordered cells. In the model group, the cerebral cortex layers of the right hemisphere were not defined, neurons were damaged, and neurons were disarranged in the hippocampal area. In the GM1 group, neurons were dense in the right cerebral cortex and hippocampal area. with no significant change in glial proliferation. (2) The average time of escape latency in the GM1 group was shortened 4 weeks after surgery, and significantly less than the model group (P < 0.05). In addition, the frequency platform passing in the GM1 group was significantly greater than the model group (P < 0.01).CONCLUSION: Exogenous GM1 may reduce brain injury and improve learning and memory in hypoxia-ischemia-induced brain damage rats. This protection may be associated with increased growth-associated protein-43 expression. which is involved in neuronal remodeling processes.

GM1 ameliorates neuronal injury in rats after cerebral ischemia and reperfusion: Potential contribution of effects on SPTBN1-mediated signaling

Protection Against Experimental Stroke by Ganglioside GM1 is Associated with the Inhibition of Autophagy

GM1 stabilizes expression of NMDA receptor subunit 1 in the ischemic hemisphere of MCAo/reperfusion rat

The neuroprotective effects of GM1 on rat global cerebral ischemic reperfusion damage

Monosialotetrahexosy-1 Ganglioside Attenuates Diabetes-Associated Cerebral Ischemia/reperfusion Injury Through Suppression of the Endoplasmic Reticulum Stress-Induced Apoptosis.

Monosialoganglioside Protected Ischemic Rat Hippocampal Slices Through Stabilizing Expression of N-Methyl-D-Aspartate Receptor Subunit

The Protective Effect of Monosialoganglioside-GM1 on Severe Traumatic Brain Injury

Effect of Gangliaside GM1 on Induced Nitric Oxide Synthase after Focal Cerebral Ischemical Reperfusion in Rats

Ginsenoside-MC1 Alleviates Stroke by Modulating AMPK/SIRT1 Pathway in a Rat Model

[Study on Protective Effect of Monosialoganglioside (GM1) on Injury Induced by Oxygen Glucose Deprivation/reperfusion in Rat Hippocampal Slices].

The Possible Damaged Mechanism and the Preventive Effect of Monosialotetrahexosylganglioside in a Rat Model of Cerebral Ischemia-Reperfusion Injury.

Protective Effect of GM1 on Cerebral Ischemia-Reperfusion Injury in Rats

Effects of Exogenous Ganglioside-1 on Learning and Memory in A Neonatal Rat Model of Hypoxia-Ischemia Brain Injury

SIRT1/PGC-1α signaling activation by mangiferin attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells

Motoneuronotrophic Factor Analog GM6 Reduces Infarct Volume and Behavioral Deficits Following Transient Ischemia in the Mouse.

Gomisin N Attenuated Cerebral Ischemia-Reperfusion Injury Through Inhibition of Autophagy by Activating the PI3K/AKT/mTOR Pathway

Hmgb1-Triggered Inflammation Inhibition Of Notoginseng Leaf Triterpenes Against Cerebral Ischemia And Reperfusion Injury Via Mapk And Nf-Kappa B Signaling Pathways

Protective Effects of Monosialotetrahexosylganglioside Sodium on H2O2-induced Human Vascular Endothelial Cells.

Ganglioside GM1 and Central Nervous System Diseases

Effect of gangliaside GM-1 on nitric oxide synthase after focal cerebral ischemia in rats

HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways